Cowan, R., Scarisbrick, J. J., Zinzani, P. L., Nicolay, J. P., Sokol, L., Pinter-Brown, L., . . . Medley, M. C. (2021). Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: A post hoc analysis of the MAVORIC trial. Journal of the European Academy of Dermatology and Venereology, 35(11), . https://doi.org/10.1111/jdv.17523
Chicago-Zitierstil (17. Ausg.)Cowan, Richard, et al. "Efficacy and Safety of Mogamulizumab by Patient Baseline Blood Tumour Burden: A Post Hoc Analysis of the MAVORIC Trial." Journal of the European Academy of Dermatology and Venereology 35, no. 11 (2021). https://doi.org/10.1111/jdv.17523.
MLA-Zitierstil (9. Ausg.)Cowan, Richard, et al. "Efficacy and Safety of Mogamulizumab by Patient Baseline Blood Tumour Burden: A Post Hoc Analysis of the MAVORIC Trial." Journal of the European Academy of Dermatology and Venereology, vol. 35, no. 11, 2021, https://doi.org/10.1111/jdv.17523.